S. Cutrupi

C. Zoccali, G. D’Arrigo, F. Mallamaci, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Active vitamin D treatment in CKD patients raises serum sclerostin and this effect is modified by circulating pentosidine levels.

C. Zoccali, R. Thadhani, F. Mallamaci, 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

FGF23 and the PTH response to paricalcitol in chronic kidney disease

C. Zoccali, G. D’Arrigo, F. Mallamaci, 2019, European journal of clinical investigation.

Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD).

C. Zoccali, F. Mallamaci, P. Fatuzzo, 2003, Kidney International.

Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients.

C. Zoccali, F. Mallamaci, G. Tripepi, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.

C. Zoccali, F. Mallamaci, G. Tripepi, 2005, Kidney international.

Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients.

C. Zoccali, F. Mallamaci, P. Fatuzzo, 1999, Journal of nephrology.

Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients.

C. Zoccali, F. Mallamaci, G. Tripepi, 2005, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients.

C. Zoccali, F. Mallamaci, P. Fatuzzo, 2002, Kidney international.

C. Zoccali, F. Mallamaci, G. Bonanno, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Norepinephrine and Concentric Hypertrophy in Patients With End-Stage Renal Disease

C. Zoccali, F. Mallamaci, G. Tripepi, 2002, Hypertension.

Adiponectin in essential hypertension.

S. Kihara, T. Funahashi, Y. Matsuzawa, 2002, Journal of nephrology.

Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure

C. Zoccali, M. Buemi, F. Mallamaci, 2003, European journal of clinical investigation.

Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections.

C. Zoccali, R. Maas, G. Tripepi, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Selenoprotein P-1 (SEPP1) as an Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass

D. Bolignano, G. Coppolino, M. Andreucci, 2022, Reviews in Cardiovascular Medicine.

Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patients.

D. Bolignano, C. Zoccali, L. Ghiadoni, 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Low triiodothyronine and survival in end-stage renal disease.

C. Zoccali, F. Mallamaci, G. Tripepi, 2006, Kidney international.

Urotensin II in end-stage renal disease: an inverse correlate of sympathetic function and cardiac natriuretic peptides.

C. Zoccali, F. Mallamaci, G. Tripepi, 2005, Journal of nephrology.

Procalcitonin and the inflammatory response to salt in essential hypertension: a randomized cross-over clinical trial

C. Zoccali, F. Mallamaci, G. Tripepi, 2013, Journal of hypertension.

Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients.

C. Zoccali, F. Mallamaci, G. Tripepi, 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis.

C. Zoccali, F. Mallamaci, G. Tripepi, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease

C. Zoccali, F. Mallamaci, G. Bonanno, 2006, Journal of hypertension.

Low triiodothyronine: a new facet of inflammation in end-stage renal disease.

C. Zoccali, F. Mallamaci, G. Tripepi, 2005, Journal of the American Society of Nephrology : JASN.

Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study

P. Boscolo-Rizzo, L. Vaira, F. Maglitto, 2021, The Journal of Laryngology & Otology.

Renal endothelin-1 is linked to changes in urinary salt and volume in essential hypertension. Salt Sensitivity Group of the Italian Society of Hypertension.

C. Zoccali, N. Glorioso, R. Mangiafico, 2000, Journal of nephrology.

Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease

C. Zoccali, F. Mallamaci, G. Bonanno, 2003, Journal of hypertension.

Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study

C. Zoccali, F. Mallamaci, C. Torino, 2019, Journal of clinical medicine.

Intact FGF23 and α‐klotho during acute inflammation/sepsis in CKD patients

C. Zoccali, G. D’Arrigo, F. Mallamaci, 2017, European journal of clinical investigation.

Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients.

C. Zoccali, G. D’Arrigo, F. Mallamaci, 2016, NMCD. Nutrition Metabolism and Cardiovascular Diseases.

Low parathyroid hormone and pentosidine in hemodialysis patients.

C. Zoccali, T. Miyata, F. Mallamaci, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.

C. Zoccali, F. Mattace-Raso, E. Sijbrands, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Neuropeptide Y and markers of osteoblast activity in dialysis patients: a cross-sectional study.

C. Zoccali, F. Mallamaci, G. Tripepi, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

IgM and IgG antibodies to hepatitis C virus in patients with mixed cryoglobulinaemia

S. Cutrupi, A. Craxì, C. Fabiano, 1993, Clinical and experimental immunology.

Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients

C. Zoccali, M. Postorino, D. Galati, 2018, Kidney international reports.

Salivary and lacrimal secretion is reduced in patients with ESRD.

C. Zoccali, M. Postorino, C. Catalano, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[Xerostomia and Xerophthalmia in haemodialysis patients].

C. Zoccali, M. Postorino, S. Cutrupi, 2002, Giornale Italiano di Nefrologia.

Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease.

R. de Caterina, G. Basta, F. Mallamaci, 2010, Kidney international.

Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients.

F. Mattace-Raso, E. Sijbrands, G. D’Arrigo, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease

C. Zoccali, F. Mallamaci, G. Bonanno, 2002, Circulation.

Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all‐cause and cardiovascular mortality in haemodialysis patients

C. Zoccali, M. Postorino, G. Tripepi, 2011, Journal of internal medicine.

Vitamin D receptor activation by paricalcitol and insulin resistance in CKD.

C. Zoccali, F. Mallamaci, G. Tripepi, 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors.

S. Kihara, T. Funahashi, Y. Matsuzawa, 2003, Kidney international. Supplement.

Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

S. Kihara, T. Funahashi, Y. Matsuzawa, 2002, Journal of the American Society of Nephrology : JASN.

Vitamin D and methylarginines in chronic kidney disease (CKD)

C. Zoccali, F. Mallamaci, C. Torino, 2017, PloS one.

Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients

C. Zoccali, F. Mallamaci, G. Bonanno, 2008, Journal of hypertension.

Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease.

C. Zoccali, F. Mallamaci, G. Tripepi, 2006, Kidney international.

Gender-dependent differences in plasma leptin in essential hypertension.

C. Zoccali, F. Mallamaci, G. Tripepi, 2000, American Journal of Hypertension.

Efficacy of corticosteroid therapy in the treatment of long- lasting olfactory disorders in COVID-19 patients.

C. Hopkins, L. Vaira, G. De Riu, 2020, Rhinology.

Long term effects of cryoapheresis and cytostatic treatment in essential mixed cryoglobulinemia.

S. Cutrupi, Q. Maggiore, A. Caccamo, 1985, The International journal of artificial organs.

Intact FGF23 and α‐klotho during acute inflammation/sepsis in CKD patients

C. Zoccali, G. D’Arrigo, F. Mallamaci, 2016, European journal of clinical investigation.

Studies on Hemodialysis Hyperthermia

C. Catalano, G. Enia, S. Cutrupi, 1984 .

Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial.

C. Zoccali, G. D’Arrigo, L. Gesualdo, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Leptin and biochemical markers of bone turnover in dialysis patients.

C. Zoccali, F. Mallamaci, G. Tripepi, 2004, Journal of nephrology.

Dermal Substitutes and Skin Grafts in the Reconstruction of Post-Traumatic Total Scalp Avulsion: A Case Series

L. Vaira, L. Califano, G. Salzano, 2023, Journal of clinical medicine.

Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.

C. Zoccali, F. Mattace-Raso, E. Sijbrands, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients

C. Zoccali, F. Mallamaci, C. Torino, 2017, Oxidative medicine and cellular longevity.

Role of Gut Microbiota in Overweight Susceptibility in an Adult Population in Italy

G. Pioggia, G. Tripepi, S. Cutrupi, 2023, Nutrients.

Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients

C. Zoccali, F. Mallamaci, G. Bonanno, 2008, Journal of hypertension.